- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Secondary-progressive Multiple Sclerosis in United Kingdom
Total 1526 results
-
University of NottinghamSwansea University; Multiple Sclerosis Society UKCompleted
-
University College, LondonUniversity College London HospitalsUnknownMultiple SclerosisUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompleted
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
ActelionCompletedRaynaud's Phenomenon Secondary to Systemic SclerosisGermany, France, United Kingdom
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
Queen Mary University of LondonRecruiting
-
East Kent Hospitals University NHS Foundation TrustCompleted
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | SpasticityUnited Kingdom
-
Jazz PharmaceuticalsCompletedMultiple SclerosisUnited Kingdom
-
Imperial College LondonRecruitingMultiple SclerosisUnited Kingdom
-
Glasgow Caledonian UniversityNHS Lanarkshire; MS Society, UKCompletedMultiple SclerosisUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustTerminatedMultiple SclerosisUnited Kingdom
-
North Bristol NHS TrustSir Halley Stewart TrustCompletedMultiple SclerosisUnited Kingdom
-
University of the West of ScotlandNational Heatlh Service Ayrshire and ArranUnknown
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Queen Margaret UniversityMultiple Sclerosis Society of Great BritainRecruitingMultiple SclerosisUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedMultiple SclerosisUnited Kingdom
-
University of GlasgowNHS Lothian; University of Plymouth; University Hospital Plymouth NHS Trust; National...CompletedMultiple SclerosisUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Queen Mary University of LondonTerminated
-
AbbVieTerminatedMultiple SclerosisUnited Kingdom
-
Thomas Jefferson UniversityRecruitingRelapse Remitting Multiple SclerosisUnited States
-
Waukesha Memorial HospitalThe Cleveland ClinicCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
University of EdinburghCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
University of North Carolina, Chapel HillGenzyme, a Sanofi CompanyTerminatedRELAPSING REMITTING MULTIPLE SCLEROSISUnited States
-
Ohio State UniversityNational Multiple Sclerosis SocietyCompleted
-
NeurognosticsCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis, Relapsing Forms of Multiple SclerosisSpain, Canada, France, Switzerland, Italy, Portugal, Denmark, Poland, Germany, United Kingdom
-
Novartis PharmaceuticalsTerminatedRelapse Remitting Multiple SclerosisUnited States, Ukraine, Czechia
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
Newcastle-upon-Tyne Hospitals NHS TrustCompletedMultiple SclerosisUnited Kingdom
-
Teva Pharmaceutical Industries, Ltd.TerminatedRelapsing Remitting Multiple SclerosisCzechia, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
Kessler FoundationActive, not recruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
University of Missouri, Kansas CityCompletedRelapsing-remitting Multiple SclerosisUnited States
-
University of Missouri, Kansas CityNational Multiple Sclerosis SocietyCompletedRelapsing-remitting Multiple SclerosisUnited States
-
PfizerArena is a wholly owned subsidiary of PfizerTerminatedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited Kingdom, United States
-
Sheffield Hallam UniversitySheffield Teaching Hospitals NHS Foundation TrustCompletedMultiple SclerosisUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustSheffield Hallam UniversityCompletedMultiple SclerosisUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompleted
-
University of EdinburghNHS LothianCompletedMultiple Sclerosis | Psychological DistressUnited Kingdom
-
NeurognosticsTerminatedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
University of NottinghamUnknownCarer Stress SyndromeUnited Kingdom
-
Providence Multiple Sclerosis CenterBiogenCompletedClinically Isolated Syndrome | Relapsing-remitting Multiple SclerosisUnited States